Figure 4.

Cumulative Risks of the Study Outcomes in the Matched Cohorts of Sutureless/RD-AVR and TAVR

Event rates were shown by use of Kaplan-Meier estimates of the rates of (A)the primary composite end point and the individual components of the primary end point, ie, (B) death from any cause, (C) stroke, and (D) rehospitalization), in patients who underwent rapid deployment aortic-valve replacement (Sutureless/RD-AVR) and those who underwent transaortic aortic-valve replacement (SAVR). Abbreviations as in Figures 1 and 2.